ADMA
ADMA
Positions held
Your positionsADMA isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors
2026-10-08 · ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know
2026-09-29 · Here's Why Adma Biologics (ADMA) Fell More Than Broader Market
2026-09-27 · ADMA Biologics (ADMA), Why Is It Back In The Spotlight?
2026-09-24 · Why Adma Biologics (ADMA) Dipped More Than Broader Market Today
2026-09-24 · Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
2026-09-18 · Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know
2026-09-11 · Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know
2026-09-10 · Adma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to Know
2026-09-08 · Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?
2026-09-04 · Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound?
2026-08-06 · ADMA Q2 Earnings Meet, Revenues Miss on Bivigam Weakness
Price (daily)
Full chart · RSI · MACD · patterns